2007 Workshop of the Society for Hematopathology and European Association for Haematopathology

Abstract

The August and September issues of the Journal will include a series of proceedings from the Workshop of the Society for Hematopathology and European Association for Haematopathology, which was held in Indianapolis, IN, in November 2007. The Workshop focused on chronic myeloproliferative neoplasms (MPNs), myeloproliferative/myelodysplastic neoplasms, de novo and therapy-related myelodysplastic syndromes (MDS), extramedullary myeloid tumors, and mastocytosis. Cases of de novo acute myeloid leukemia were excluded. The goals of the Workshop were to correlate diagnostic hematopathology practice to the most recent discoveries in myeloid neoplasms and address diagnostic challenges through case discussions. The Workshop and preparation of the proceedings coincided with the update of the World Health Organization (WHO) classification of hematopoietic and lymphoid neoplasms; thus, the articles discuss the individual diagnostic entities and submitted cases in light of this updated classification published in September 2008.1 The Workshop included plenary sessions and scientific lectures. The latter aimed to review recent advances in pathogenesis of my-eloid neoplasms and developments in molecularly targeted therapies and to outline the role of molecular pathology and cytogenetics in determining the prognosis and monitoring of myeloid neoplasms. The plenary sessions included interesting cases selected to represent current issues in the diagnosis of myeloid neoplasms. The diagnostic approach was based on a careful integration of morphologic assessment with ancillary …